Chemed Corporation
CHE NYSE
ISIN US16359R1032 SEC CIK 19584 LEI 54930020031IDJT2IM79
Follow Chemed
Weekly email: filings, results
Revenue, last quarter
$690.9M
+10.6% vs same quarter last year
Net income
$71.6M
+11.5% vs same quarter last year
EPS, diluted
$5.45
+22.2% vs same quarter last year
Operating cash flow
$56.6M
−32.1% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $2.5B | $265.2K |
| FY24 | $1.5B | $302K |
| FY23 | $1.3B | $272.5K |
| FY22 | $1.2B | $249.6K |
| FY21 | $1.3B | $268.6K |
| FY20 | $1.3B | $319.5M |
| FY19 | $1.3B | $219.9M |
| FY18 | $1.2B | $205.5M |
| FY17 | $1.7B | $98.2M |
| FY16 | $1.6B | $108.7M |
| FY15 | $1.5B | $110.3M |
| FY14 | $1.5B | $99.3M |
| FY13 | $1.4B | $77.2M |
| FY12 | $1.4B | $89.3M |
| FY11 | $1.4B | $86M |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 32.5% | 13.4% | 0% |
| FY24 | −3% | 23.9% | 0% |
| FY23 | −11.4% | 25.9% | 0% |
| FY22 | −14% | 28.6% | 0% |
| FY21 | −8.6% | 27.2% | 0% |
| FY20 | −3.3% | 29.2% | 23.9% |
| FY19 | −3.1% | 20.1% | 17.2% |
| FY18 | −2.5% | 20.3% | 17.2% |
| FY17 | 31% | 6.8% | 5.9% |
| FY16 | 29.3% | 11.3% | 6.9% |
| FY15 | 29.5% | 12% | 7.1% |
| FY14 | 29% | 11.6% | 6.8% |
| FY13 | 28.6% | 9.4% | 5.5% |
| FY12 | 27.7% | 10.9% | 6.2% |
| FY11 | 28.4% | 11.3% | 6.3% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | $325.5M |
| FY24 | $368M |
| FY23 | $273.4M |
| FY22 | $252.6M |
| FY21 | $249.9M |
| FY20 | $430.5M |
| FY19 | $248.2M |
| FY18 | $234.3M |
| FY17 | $98.2M |
| FY16 | $95.6M |
| FY15 | $127.4M |
| FY14 | $66.7M |
| FY13 | $121.5M |
| FY12 | $96.5M |
| FY11 | $144.8M |
- Dividends
- Buybacks
Show the numbers
| Year | Dividends | Buybacks |
|---|---|---|
| FY25 | $31.7M | $431.5M |
| FY24 | $27.1M | $361.4M |
| FY23 | $23.5M | $67.7M |
| FY22 | $22M | $114.5M |
| FY21 | $22M | $576M |
| FY20 | $21.1M | $175.6M |
| FY19 | $19.8M | $92.6M |
| FY18 | $18.7M | $158.9M |
| FY17 | $17.4M | $94.6M |
| FY16 | $16.4M | $102.3M |
| FY15 | $15.6M | $59.3M |
| FY14 | $14.3M | $110M |
| FY13 | $14.1M | $92.9M |
| FY12 | $13M | $60.6M |
| FY11 | $12.5M | $144M |
- Chemed
- Healthcare median
Show the numbers
| Year | Chemed | Healthcare median |
|---|---|---|
| FY25 | 0% | −30.6% |
| FY24 | 0% | −47% |
| FY23 | 0% | −58% |
| FY22 | 0% | −80.4% |
| FY21 | 0% | −71.9% |
| FY20 | 23.9% | −62.2% |
| FY19 | 17.2% | −46.3% |
| FY18 | 17.2% | −49.6% |
| FY17 | 5.9% | −45.9% |
| FY16 | 6.9% | −36% |
| FY15 | 7.1% | −38.4% |
| FY14 | 6.8% | −35.5% |
| FY13 | 5.5% | −37.1% |
| FY12 | 6.2% | −29.1% |
| FY11 | 6.3% | −27.9% |